Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Fluidigm Ink Deal to Co-market Access Array Platform with 454 Sequencing


By Justin Petrone

Fluidigm and Roche 454 Life Sciences this week announced that they have entered a worldwide co-promotional agreement that pairs Fluidigm's amplicon sample-preparation platform with Roche 454's high-throughput sequencers.

The partners will market Fluidigm’s Access Array System for use in target enrichment prior to sequencing on Roche 454's GS Junior or GS FLX System.

Launched last year, Access Array enables automated processing of 48 samples against 48 amplicons, resulting in PCR products that are ready for emPCR amplification. Amplicon sample preparation can take weeks using traditional approaches, the firms noted.

In addition to sequencing library preparation using amplicon tagging, the integrated fluidic circuit-based platform supports sample capture and target enrichment and sample barcoding for multiplexed sequencing, according to South San Francisco, Calif.-based Fluidigm.

454 CEO and President Christopher McLeod said the Access Array System and GS Junior are "extremely complementary," and enable the analysis of "large numbers of sample/amplicon combinations in an affordable workflow without the need for complicated liquid handling."

A single Access Array plate on a single GS Junior System run "generates as much data as hundreds, even thousands, of 96-well plates analyzed on a capillary sequencing system," McLeod said.

Financial terms of the deal were not discussed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more